Idiopathic Hypersomnolence Summary

32 relevant articles (2 outcomes, 3 trials/studies) found for this Disease

Description: A sleep disorder of central nervous system origin characterized by prolonged nocturnal sleep and periods of daytime drowsiness. Affected individuals experience difficulty with awakening in the morning and may have associated sleep drunkenness, automatic behaviors, and memory disturbances. This condition differs from narcolepsy in that daytime sleep periods are longer, there is no association with CATAPLEXY, and the multiple sleep latency onset test does not record sleep-onset rapid eye movement sleep. (From Chokroverty, Sleep Disorders Medicine, 1994, pp319-20; Psychiatry Clin Neurosci 1998 Apr:52(2):125-129)

Also Known As: Hypersomnolence, Idiopathic; Idiopathic Central Nervous System Hypersomnolence; Idiopathic Hypersomnia; CNS Hypersomnolence, Idiopathic; CNS Hypersomnolences, Idiopathic Show All >>

Key Drugs and Agents for Idiopathic Hypersomnolence

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

modafinil (armodafinil) : 1 outcome in 9 results : FDA 9
orexins (orexin) : 1 outcome in 6 results : IBA
STF 62247 : 1 outcome in 1 result : IBA
acetamide : 1 outcome in 1 result : IBA
diphenyl (biphenyl) : 1 outcome in 1 result : IBA
tranilast (N 5') : 1 study in 2 results : IBA
Cytokines : 1 study in 1 result : IBA
Interleukin-6 (Interleukin 6) : 1 study in 1 result : IBA
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 1 study in 1 result : IBA
human HLA-DQB1 protein : 1 study in 1 result : IBA

Show All >>

Diseases Related to Idiopathic Hypersomnolence

Show All >>

Key Therapies for Idiopathic Hypersomnolence

Efficacy Chart >>